Login / Signup

Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia.

Dawei CuiYan LvXinwang YuanGuoxiang RuanYu ZhangCuilin YanDandan XuMengen LvYun MaoJianping CaoJie JinYushan Xu
Published in: Journal of immunology research (2019)
These data indicated that increased expression levels of OX40 and OX40L were involved in the pathogenesis of ITP, and OX40 and OX40L may be valuable therapeutic targets for ITP.
Keyphrases
  • low density lipoprotein
  • poor prognosis
  • electronic health record
  • machine learning
  • artificial intelligence